Delaware (State or other jurisdiction of incorporation or organization) |
1-11397 (Commission File Number) |
33-0628076 (IRS Employer Identification No.) |
One Enterprise Aliso Viejo, California (Address of principal executive offices) |
92656 (Zip Code) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | ||||||||
Item 9.01 Financial Statements and Exhibits | ||||||||
SIGNATURES | ||||||||
EXHIBIT 3.1 |
Item 5.03 | Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. |
Item 9.01 | Financial Statements and Exhibits. |
Exhibit | ||
Number | Exhibit Description | |
3.1
|
Amended and Restated Bylaws |
2.
Valeant Pharmaceuticals International |
||||
Date: February 25, 2008 | By: | /s/ Eileen C. Pruette | ||
Eileen C. Pruette | ||||
Executive Vice President, General Counsel | ||||
3.
Exhibit No. | Description | |
3.1
|
Amended and Restated Bylaws |